Evidence map›Paper›PMID 29483713›Full record

ArticleLeukemia2018

MicroRNA-101 expression is associated with JAK2V617F activity and regulates JAK2/STAT5 signaling.

Francesca Pagano, Federico Comoglio, Jacob Grinfeld, Juan Li, Anna Godfrey, Joanna Baxter, Yvonne Silber, Anthony R Green

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Francesca PaganoCambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Hills Road, Cambridge, CB2 0XY, UK.
Federico ComoglioCambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Hills Road, Cambridge, CB2 0XY, UK.
Jacob GrinfeldCambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Hills Road, Cambridge, CB2 0XY, UK.
Juan LiCambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Hills Road, Cambridge, CB2 0XY, UK.
Anna GodfreyDepartment of Haematology, Cambridge University Hospitals NHS Foundation Trust Hills Road, Cambridge, CB2 0QQ, UK.
Joanna BaxterCambridge Blood and Stem Cell Biobank, Department of Haematology, University of Cambridge, National Health Service Blood and Transplant Cambridge Centre, Cambridge, UK.
Yvonne SilberCambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Hills Road, Cambridge, CB2 0XY, UK.
Anthony R GreenCambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Hills Road, Cambridge, CB2 0XY, UK. arg1000@cam.ac.uk.

Funding

Cancer Research UK 21762Medical Research Council MC_PC_12009Wellcome Trust 097922Wellcome Trust 100140
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Expression Regulation, NeoplasticMutationBiomarkers, TumorHumansJanus Kinase 2Leukemia, Erythroblastic, AcuteMicroRNAsSignal TransductionSTAT5 Transcription FactorTumor Cells, CulturedTumor Suppressor ProteinsBiomarkers, TumorJAK2 protein, humanJanus Kinase 2MicroRNAsMIRN101 microRNA, humanSTAT5A protein, humanSTAT5 Transcription FactorTumor Suppressor Proteins

Identifiers

PMID29483713
PMCPMC5989937

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.